Engineers Gate Manager’s Avidity Biosciences RNAM Stock Holding History

Engineers Gate Manager’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,298	Closed	-$238K	–	2508
2025 Q4	$238K	Buy	+3,298	New	+$213K	﹤0.01%	1737
2025 Q2	–	Sell	-27,808	Closed	-$821K	–	2485
2025 Q1	$821K	Buy	27,808 +9,931	+56%	+$309K	0.01%	1180
2024 Q4	$520K	Sell	17,877 -12,367	-41%	-$517K	0.01%	1396
2024 Q3	$1.39M	Buy	+30,244	New	+$1.31M	0.03%	819
2024 Q2	–	Sell	-9,186	Closed	-$234K	–	2186
2024 Q1	$234K	Sell	9,186 -26,334	-74%	-$413K	0.01%	1588
2023 Q4	$321K	Buy	+35,520	New	+$237K	0.01%	1419
2023 Q2	–	Sell	-17,474	Closed	-$268K	–	1984
2023 Q1	$268K	Buy	+17,474	New	+$384K	0.01%	1310

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Engineers Gate Manager's RNAM Position: Q1 2026 in Review

Engineers Gate Manager sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 3,298 shares — an estimated $238K sold.

Engineers Gate Manager first reported a position in RNAM in Q1 2023 and held it in 7 quarters. The position peaked at $1.39M in Q3 2024. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Engineers Gate Manager reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Engineers Gate Manager sold 3,298 Avidity Biosciences shares in Q1 2026, an estimated $238K.
Engineers Gate Manager first reported a position in Avidity Biosciences in Q1 2023 and held it in 7 quarters.
Engineers Gate Manager's Avidity Biosciences position peaked at $1.39M in Q3 2024.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.